These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 682811)

  • 61. American Academy of Pediatrics. Committee on drugs. Drug testing in children: FDA regulations.
    Pediatrics; 1969 Mar; 43(3):463-5. PubMed ID: 5818481
    [No Abstract]   [Full Text] [Related]  

  • 62. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Delegations of authority and organization; revised organization. Food and Drug Administration. Final rule.
    Fed Regist; 1982 Mar; 47(41):8761-3. PubMed ID: 10254381
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Removal of regulations regarding certification of drugs composed wholly or partly of insulin; companion document to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 May; 63(92):26690-3. PubMed ID: 10179340
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Revision of requirements applicable to albumin (human), plasma protein fraction (human), and immune globulin (human). Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Aug; 65(167):52016-8. PubMed ID: 11067735
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Amendment of regulations regarding certain label statements on prescription drugs. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Feb; 67(22):4904-7. PubMed ID: 11829025
    [TBL] [Abstract][Full Text] [Related]  

  • 67. FDA issues regulations for vitamins.
    Walker E
    Mod Nurs Home; 1973 Nov; 31(5):4 passim. PubMed ID: 4493593
    [No Abstract]   [Full Text] [Related]  

  • 68. Environmental assessments and findings of no significant impact--FDA. Notice.
    Fed Regist; 1998 May; 63(95):27300-3. PubMed ID: 10179346
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Protease inhibitors: FDA warns doctors of diabetes risk. Food and Drug Administration.
    AIDS Treat News; 1997 Jun; (No 273):5-6. PubMed ID: 11364400
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Administrative practices and procedures; promulgation of regulations for the efficient enforcement of law--FDA. Final rule.
    Fed Regist; 1991 Apr; 56(65):13757-8. PubMed ID: 10111150
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Amendment of various device regulations to reflect current American Society for Testing and Material citations. Food and Drug Administration, HHS. Direct final rule.
    Fed Regist; 2000 Jan; 65(15):3584-5. PubMed ID: 11010654
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Delegations of authority and organization; issuance of written notices--FDA. Final rule.
    Fed Regist; 1992 May; 57(85):18823-4. PubMed ID: 10118461
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Regulations on statements made for dietary supplements concerning the effect of the product on the structure or function of the body. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Jan; 65(4):1000-50. PubMed ID: 11010621
    [TBL] [Abstract][Full Text] [Related]  

  • 74. List of drug products that have been withdrawn or removed from the market for reasons of safety or effectiveness. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 Mar; 64(44):10944-7. PubMed ID: 10557618
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Erythrityl tetranitrate; drug efficacy study implementation; revocation of exemption; opportunity for a hearing--FDA. Notice.
    Fed Regist; 1998 Jun; 63(120):34188-90. PubMed ID: 10180293
    [TBL] [Abstract][Full Text] [Related]  

  • 76. FDA adds regulations to reduce Salmonella illness from eggs.
    Cima G
    J Am Vet Med Assoc; 2009 Oct; 235(7):802. PubMed ID: 19835015
    [No Abstract]   [Full Text] [Related]  

  • 77. FDA policy on unapproved drug products: past, present, and future.
    Chhabra R; Kremzner ME; Kiliany BJ
    Ann Pharmacother; 2005; 39(7-8):1260-4. PubMed ID: 15956239
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Studying new drugs for HCV. Excerpts from the FDA hearing.
    Huff B
    GMHC Treat Issues; 2006; 20(8-12):11-4. PubMed ID: 17569164
    [No Abstract]   [Full Text] [Related]  

  • 79. Expedited safety reporting requirements for human drug and biological products; correction--FDA. Final rule; correction.
    Fed Regist; 1998 Mar; 63(58):14611-2. PubMed ID: 10177754
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Delegations of authority and organization; Office of the Commissioner--FDA. Final rule.
    Fed Regist; 1991 Nov; 56(225):58758. PubMed ID: 10115698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.